HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefan Barth Selected Research

BB 3644

9/2004Metalloproteinase inhibition augments antitumor efficacy of the anti-CD30 immunotoxin Ki-3(scFv)-ETA' against human lymphomas in vivo.
3/2002Inhibition of metalloproteinases enhances the internalization of anti-CD30 antibody Ki-3 and the cytotoxic activity of Ki-3 immunotoxin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefan Barth Research Topics

Disease

63Neoplasms (Cancer)
09/2021 - 02/2002
8Breast Neoplasms (Breast Cancer)
10/2019 - 04/2003
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2016 - 12/2003
6Hodgkin Disease (Hodgkin's Disease)
10/2016 - 06/2004
6Rhabdomyosarcoma
05/2016 - 02/2013
6Lymphoma (Lymphomas)
04/2014 - 06/2004
4Leukemia
01/2017 - 12/2015
3Malaria
01/2021 - 07/2015
3Skin Neoplasms (Skin Cancer)
01/2021 - 05/2016
3Melanoma (Melanoma, Malignant)
10/2020 - 05/2016
3Necrosis
10/2020 - 08/2016
3Triple Negative Breast Neoplasms
08/2016 - 01/2016
3Infections
02/2016 - 06/2011
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2010 - 10/2003
2Neoplasm Metastasis (Metastasis)
10/2019 - 02/2005
2Prostatic Neoplasms (Prostate Cancer)
10/2017 - 11/2008
2Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
10/2016 - 09/2014
2Myeloid Leukemia (Leukemia, Myelocytic)
10/2016 - 12/2015
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2016 - 08/2015
2Acute Myelomonocytic Leukemia
12/2015 - 09/2014
2Carcinoma (Carcinomatosis)
09/2014 - 04/2003
2Inflammation (Inflammations)
01/2012 - 06/2011
2Carcinogenesis
06/2009 - 10/2003
1Arthrogryposis renal dysfunction cholestasis syndrome
09/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021
1Mycoses (Diseases, Fungus)
01/2018
1Communicable Diseases (Infectious Diseases)
01/2018
1Hyperalgesia
01/2018
1Neuralgia (Stump Neuralgia)
01/2018
1Pain (Aches)
01/2018
1Hypersensitivity (Allergy)
01/2018
1Acute-Phase Reaction
01/2018
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2017
1Atopic Dermatitis (Atopic Eczema)
09/2017

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
02/2019 - 06/2004
20Immunotoxins (Immunotoxin)IBA
09/2020 - 02/2002
19AntigensIBA
01/2021 - 04/2003
12AntibodiesIBA
09/2021 - 04/2003
10ErbB Receptors (EGF Receptor)IBA
10/2016 - 10/2003
9Immunoconjugates (Immunoconjugate)IBA
09/2021 - 08/2013
8Monoclonal AntibodiesIBA
01/2021 - 06/2009
7Immunoglobulin FragmentsIBA
05/2016 - 01/2005
6Pharmaceutical PreparationsIBA
10/2020 - 08/2013
6Granzymes (Granzyme)IBA
06/2018 - 09/2008
6LigandsIBA
01/2018 - 10/2003
5Photosensitizing Agents (Photosensitizers)IBA
01/2021 - 12/2011
4EnzymesIBA
09/2021 - 04/2003
4Small Interfering RNA (siRNA)IBA
09/2021 - 11/2008
4Coloring Agents (Dyes)IBA
10/2020 - 10/2010
3Peptides (Polypeptides)IBA
09/2021 - 10/2005
31-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2021 - 09/2020
3Indicators and Reagents (Reagents)IBA
11/2018 - 10/2003
3Death-Associated Protein KinasesIBA
10/2017 - 01/2009
3chondroitin sulfate proteoglycan 4IBA
06/2017 - 01/2016
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
10/2016 - 01/2014
3IgG Receptors (Fc gamma RI)IBA
10/2016 - 09/2009
3Epithelial Cell Adhesion MoleculeIBA
08/2016 - 09/2014
3Single-Chain AntibodiesIBA
12/2015 - 10/2010
3Messenger RNA (mRNA)IBA
06/2009 - 04/2003
2Membrane Proteins (Integral Membrane Proteins)IBA
10/2020 - 07/2015
2Bacterial ToxinsIBA
09/2020 - 01/2016
2Recombinant ProteinsIBA
01/2019 - 09/2017
2auristatinIBA
01/2017 - 10/2016
2Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
01/2017 - 01/2016
2human ERBB2 proteinIBA
08/2016 - 01/2016
2SerpinsIBA
05/2016 - 12/2013
2ParaffinIBA
12/2015 - 08/2015
2Formaldehyde (Formol)FDA Link
12/2015 - 08/2015
2Cetuximab (Erbitux)FDA Link
12/2015 - 02/2012
2Peptide Elongation Factor 2 (EF-2)IBA
06/2013 - 11/2008
2CytokinesIBA
06/2011 - 06/2004
2Phosphotransferases (Kinase)IBA
06/2009 - 01/2009
2Immunoglobulin G (IgG)IBA
09/2008 - 12/2003
2425(scFv)-ETA'IBA
02/2005 - 10/2003
2Metalloproteases (Metalloproteinases)IBA
09/2004 - 03/2002
2BB 3644IBA
09/2004 - 03/2002
1enhanced green fluorescent proteinIBA
09/2021
1Cell-Penetrating PeptidesIBA
09/2021
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
09/2021
1VaccinesIBA
01/2021
1AutoantigensIBA
01/2021
1Complement System Proteins (Complement)IBA
01/2021
1hypericinIBA
10/2020
1Dacarbazine (DIC)FDA LinkGeneric
10/2020
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
10/2020
1Biomarkers (Surrogate Marker)IBA
02/2019
1Pancreatic Ribonuclease (Ribonuclease A)IBA
03/2018
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1Cytotoxins (Cytolysins)IBA
11/2017
1AminopeptidasesIBA
11/2017

Therapy/Procedure

28Therapeutics
01/2021 - 02/2005
18Immunotherapy
09/2020 - 03/2002
4Drug Therapy (Chemotherapy)
09/2020 - 04/2014
3Photochemotherapy (Photodynamic Therapy)
01/2021 - 12/2011
3Precision Medicine
09/2017 - 05/2016
2Radiotherapy
01/2021 - 04/2014
1Intravenous Administration
09/2021
1RNAi Therapeutics
10/2019
1Laser Therapy (Surgery, Laser)
01/2018